Antitumor activity of 7‑O‑succinyl macrolactin A tromethamine salt in the mouse glioma model

  • Authors:
    • Jun Jin
    • Suh Hee Choi
    • Jung Eun Lee
    • Jin‑Deok Joo
    • Jung Ho Han
    • Su‑Young Park
    • Chae‑Yong Kim
  • View Affiliations

  • Published online on: March 27, 2017     https://doi.org/10.3892/ol.2017.5918
  • Pages: 3767-3773
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Chemoradiotherapy with temozolomide is the current standard treatment option for patients with glioblastoma. However, the majority of patients with glioblastoma survive for <2 years. Therefore, it is necessary to develop more effective therapeutic strategies for the treatment of glioblastoma. 7‑O‑succinyl macrolactin A tromethamine salt (SMA salt), a macrolactin compound, is known to possess an antiangiogenic activity. The present study investigated the antitumor effects of SMA salt in the treatment of glioblastoma by evaluating in vitro and in vivo antitumor effects of SMA salt in an experimental glioblastoma model. The antitumor effects of the drug on human glioblastoma U87MG, U251MG and LN229 cell lines were assessed using in vitro cell viability, migration and invasion assays. Nude mice with established U87MG glioblastoma were assigned to either the control or SMA salt treatment group. The volume of tumors and the duration of survival were also measured. SMA salt affected cell viability and caused a concentration‑dependent inhibition effect on the migration and invasion of glioblastoma cell lines. Animals in the SMA salt treatment group demonstrated a significant reduction in tumor volume and an increase in survival (P<0.05). Treatment with SMA salt presented more cytotoxic effects as well as anti‑migration and anti‑invasion activity compared with the control group in vitro and in vivo. These results suggest that SMA salt has significant antitumor effects on glioblastoma.
View Figures
View References

Related Articles

Journal Cover

May-2017
Volume 13 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jin J, Choi SH, Lee JE, Joo JD, Han JH, Park SY and Kim CY: Antitumor activity of 7‑O‑succinyl macrolactin A tromethamine salt in the mouse glioma model. Oncol Lett 13: 3767-3773, 2017
APA
Jin, J., Choi, S.H., Lee, J.E., Joo, J., Han, J.H., Park, S., & Kim, C. (2017). Antitumor activity of 7‑O‑succinyl macrolactin A tromethamine salt in the mouse glioma model. Oncology Letters, 13, 3767-3773. https://doi.org/10.3892/ol.2017.5918
MLA
Jin, J., Choi, S. H., Lee, J. E., Joo, J., Han, J. H., Park, S., Kim, C."Antitumor activity of 7‑O‑succinyl macrolactin A tromethamine salt in the mouse glioma model". Oncology Letters 13.5 (2017): 3767-3773.
Chicago
Jin, J., Choi, S. H., Lee, J. E., Joo, J., Han, J. H., Park, S., Kim, C."Antitumor activity of 7‑O‑succinyl macrolactin A tromethamine salt in the mouse glioma model". Oncology Letters 13, no. 5 (2017): 3767-3773. https://doi.org/10.3892/ol.2017.5918